CD8+/DR+/CD25--T-lymphocytes associated with marrow graft failure

Area of Science:

• Immunology
• Hematology
• Transplantation Medicine

Background:

• Graft failure after T cell-depleted marrow transplantation can occur despite HLA-identical donors.
• Understanding the immune cell characteristics in patients with poor graft function is crucial for improving transplant outcomes.

Purpose of the Study:

• To investigate the phenotypic and functional characteristics of peripheral blood mononuclear cells (PBMC) in patients experiencing poor graft function post-marrow transplantation.
• To compare these characteristics with those of patients with good graft function and healthy individuals.

Main Methods:

• Phenotypic analysis of PBMC using flow cytometry (e.g., CD3+, CD8+, DR antigens, CD25).
• Functional assays including assessment of cytolytic activity and lymphokine-activated killer (LAK) activity after culture with phytohemagglutinin (PHA) and interleukin-2 (IL-2).

Main Results:

• PBMC from patients with poor graft function had increased CD3+ and CD8+ cells, with CD8+ cells expressing DR antigens but not CD25, and lacking enhanced cytolytic activity.
• Cultured PBMC from these patients showed fewer CD2+ and CD4+ cells but acquired LAK activity.
• Host-mediated anti-donor cytotoxic activity was rarely detected, even after stimulation.

Conclusions:

• Defective T cell maturation may be implicated in some cases of graft failure following marrow transplantation.
• These immune cell abnormalities could be a consequence of marrow failure or a contributing factor to it by impairing hematopoietic support.